NDC 0409-0125-01 - Labetalol Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-0125
- Requested NDC
- 0409-0125-01
- Package NDCs from labels
- 0409-0125-01, 0409-0125-25
- Manufacturer
- Hospira, Inc. | Pfizer Healthcare India Private Limited
- Effective date
- 2026-09-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LABETALOL - Hospira, Inc. | Pfizer Healthcare India Private Limited | Hospira, Inc. | Pfizer Healthcare India Private Limited | 2026-09-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-0125-01 | Labetalol Hydrochloride | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 20 | 28 | |
| 0409-0125-25 | Labetalol Hydrochloride | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 28 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-0125-01 | ML - Milliliter | 0409-0125 | 3c39fa22-c2da-4058-8d0f-dd0f853a5da4 | 1 | 2023-09-05 |
| 0409-0125-25 | ML - Milliliter | 0409-0125 | 98c0b555-eb7f-448e-ba91-1fae008bdadd | 1 | 2023-09-05 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LABETALOL HYDROCHLORIDE | ACTIVE INGREDIENT | 1GEV3BAW9J | LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 13 | |
| LABETALOL | ACTIVE MOIETY | R5H8897N95 | LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 13 | |
| ANHYDROUS DEXTROSE | INACTIVE INGREDIENT | 5SL0G7R0OK | LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 13 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 13 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 13 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 13 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 13 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 30f9fdef-8781-4327-9a8d-812cb31ff041 | 2024-07-10 | Warnings, Adverse reactions | 896771 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | NCS HealthCare of KY, LLC dba Vangard Labs | 30280d40-28df-4c88-93bd-357a7c528906 | 2024-06-21 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID | Chartwell RX, LLC | 525136c9-7758-437b-b57b-94b905786825 | 2024-05-31 | Adverse reactions | 2968PHW8QP |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Gland Pharma Limited | 48caf986-3126-48e1-afcd-16d65c9cfe00 | 2024-05-21 | Warnings, Adverse reactions | 896771 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Fosun Pharma USA Inc. | 4a5ffab2-a3b8-411e-992d-7f38d508643a | 2024-05-16 | Warnings, Adverse reactions | 896771 1GEV3BAW9J |
| Labetalol hydrochloride | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | a007d945-417c-4647-ab03-95ca219d7d38 | 2024-05-01 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Oracit | CITRIC ACID AND SODIUM CITRATE | CMP Pharma, Inc. | bc26abed-8e6e-475d-8ab3-abf7d0377003 | 2023-12-07 | Adverse reactions | 2968PHW8QP |
| Phexxi | LACTIC ACID, L-, CITRIC ACID MONOHYDRATE, AND POTASSIUM BITARTRATE | Evofem, Inc. | 173ff411-7227-47b0-94dc-844e1ebaf14e | 2023-11-21 | Warnings, Adverse reactions | 2968PHW8QP |
| Labetalol hydrochloride | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | 83a6e770-207a-46bc-992d-c1ad90d1006d | 2023-10-30 | Warnings, Adverse reactions | 1GEV3BAW9J |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | 1a71964e-e6fa-443e-bfdd-f8852f8cf29e | 2023-10-26 | Warnings, Adverse reactions | 1GEV3BAW9J |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | c586ab65-56e8-4a4f-b471-902198d3e58c | 2023-10-17 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Lipotox | SQUALENE, CHOLESTERINUM, ESTRADIOL, PROGESTERONE, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM, ARSENICUM ALBUM, LYCOPODIUM CLAVATUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, PETROLEUM JELLY, PHENYL BUTAZONE, PLUMBUM METALLICUM, | BioActive Nutritional, Inc. | a1538692-ca00-4e52-9b7e-409767ee27e1 | 2023-09-05 | Warnings | Z8IX2SC1OH A2I8C7HI9T |
| Anubis Barcelona | PEG-40 HYDROGENATED CASTOR OIL, PROPYLENE GLYCOL, ALLANTOIN | ANUBIS COSMETICS SL | eb9244ea-6102-3cbe-e053-2a95a90ab8f6 | 2023-09-01 | Warnings | Z8IX2SC1OH A2I8C7HI9T |
| Anubis Barcelona Regul Oil | PROPYLENE GLYCOL, PANTHENOL, THIAMINE HCL | ANUBIS COSMETICS SL | eb8e5beb-4452-58c2-e053-2a95a90a66e0 | 2023-09-01 | Warnings | A2I8C7HI9T |
| Anubis Barcelona Regul Oil | CETEARYL ETHYLHEXANOATE, PROPYLENE GLYCOL, GLYCERYL STEARATE SE | ANUBIS COSMETICS SL | eb68c3ab-7835-1a1c-e053-2995a90a0d66 | 2023-09-01 | Warnings | Z8IX2SC1OH A2I8C7HI9T |
| Anubis Barcelona Regul OIl | PEG-40 HYDROGENATED CASTOR OIL, PROPYLENE GLYCOL, ARCTIUM MAJUS ROOT EXTRACT | ANUBIS COSMETICS SL | eb905bd0-c600-b8b2-e053-2995a90ad259 | 2023-09-01 | Warnings | Z8IX2SC1OH A2I8C7HI9T |
| Anubis Barcelona Regul Oil | PROPYLENE GLYCOL, GLYCERYL STEARATE SE, HUMULUS LUPULUS (HOPS) CONE EXTRACT | ANUBIS COSMETICS SL | eb7c418b-8bee-26a3-e053-2a95a90a4e96 | 2023-09-01 | Warnings | Z8IX2SC1OH A2I8C7HI9T |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | NorthStar Rx LLC | a2d07ec0-3718-40eb-9d0a-79c557c486b9 | 2023-04-28 | Warnings, Adverse reactions | 896771 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Cadila Pharmaceuticals Limited | 5fba93fc-4580-48c2-a1ec-5d446680adcf | 2022-12-09 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol hydrochloride | LABETALOL HYDROCHLORIDE | Proficient Rx LP | c0301841-e209-4242-bace-58a20e6dd01b | 2022-11-01 | Warnings, Adverse reactions | 1GEV3BAW9J |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.